Chlormethiazole inhibition of cytochrome p450 2E1 as assessed by chlorzoxazone hydroxylation in humans

Hepatology

Volumn 26, Issue 4, 1997, Pages 957-961

  Gebhardt, Anke C ^a   Lucas, Danièle ^b   Ménez, Jean François ^b   Seitz, Helmut K ^a  

^a Krankenhaus Salem   (Germany)

^b FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTICONVULSIVE AGENT; CHLORZOXAZONE; CLOMETHIAZOLE; CLORAZEPATE; CYTOCHROME P450; SEDATIVE AGENT;

ADULT; AGED; ALCOHOL WITHDRAWAL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG METABOLISM; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; HYDROXYLATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER MICROSOME; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030815178     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260423     Document Type: Article

References (37)

1. Koop DR, Crump BL, Nordblom GD, Coon MJ. Immunochemical evidence for induction of the alcohol-oxidizing cytochrome P-450 of rabbit liver microsomes by diverse agents: ethanol, imidazole, trichloroethylene, acetone, pyrazole and isoniazid. Proc Natl Acad Sci U S A 1985; 82:4065-4069.
2. Koop DR, Casazza JP. Identification of ethanol-inducible P-450 isozyme 3 alpha as the acetone and acetol monooxygenase of rabbit microsomes. J Biol Chem 1985;260:13607-13612.
3. Lieber CS. Biochemical and molecular bases of alcohol-induced injury to liver and other tissues. N Engl J Med 1988;319:1639-1650.
4. Ko IY, Park SS, Song BJ, Patten C, Tan YC, Hah YC, Yang CS, Gelboin HV. Monoclonal antibodies to ethanol-induced rat liver cytochrome P-450 that metabolizes aniline and nitrosamines. Cancer Res 1987;47: 3101-3109.
5. Garro AJ, Seitz HK, Lieber CS. Enhancement of dimethylnitrosamine metabolism and activation to a mutagen after chronic ethanol consumption. Cancer Res 1981;41:120-124.
6. Peter R, Böcker R, Beaune PH, Iwasaki M, Guengerich FP, Yang CS. Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem Res Toxicol 1990;3:566-573.
7. Raucy JL, Lasker JM, Lieber CS, Black M. Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch Biochem Biophys 1989;271:270-283.
8. Kharasch ED, Thummel KE. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane and methoxyflurane. Anesthesiology 1993;79:795-807.
9. Seitz HK, Osswald B. Effect of ethanol on procarcinogen activation. In: RR Watson, ed. Alcohol and Cancer. Boca Raton: CRC Press, 1992:55-72.
10. Ingelman-Sundberg M, Johansson I, Hu Y, Terelius Y, Eliasson E, Clot P, Albano E. Ethanol-inducible cytochrome P450 2E1: genetic polymorphism, regulation and possible role in the etiology of alcohol-induced liver disease. Alcohol 1993;10:447-452.
11. Albano E, Clot P, Morimoto M, Tomasi A, Ingelman-Sundberg M, French SW. Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. HEPATOLOGY 1996;23:155-163.
12. Morimoto M, Hagbjörk AL, Wan YJY, Fu PC, Clot P, Albano E, Ingelman-Sundberg M, et al. Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors. HEPATOLOGY 1995; 21:1610-1617.
13. French SW, Albano E, Hagbjörk AL, Ingelman-Sundberg M. Effect of isoniazid (INH) on ethanol-induced lipid peroxidation and serum protein adduct formation [Abstract]. HEPATOLOGY 1992;16:534A.
14. Brady JF, Xiao F, Wang MH, Li Y, Ning SM, Gapac J, Yang CS. Effects of disulfiram on hepatic P450IIE1, other microsomal enzymes and hepatotoxicity in rats. Toxicol Appl Pharmacol 1991;108:366-373.
15. Kim SG, Kwak JY, Lee JW, Novak RF, Park SS, Kim ND. Malotilate, a hepatoprotectant, suppresses CYP2E1 expression in rats. Biochem Biophys Res Commun 1994;200:1414-1420.
16. Ishizaki H, Brady JF, Ning SM, Yang CS. Effect of phenethyl isothiocyanate on microsomal N-nitroso dimethylamine (NDMA) metabolism and other monooxygenase activities. Xenobiotica 1990;20:225-264.
17. Brady JF, Wang MH, Hong JY, Xiao F, Li Y, Yoo JSH, Ning SM, et al. Modulation of rat hepatic microsomal monooxygenase activities and cytotoxicity by diallyl sulfide. Toxicol Appl Pharmacol 1991;108:342-354.
18. Morgan MY. The management of alcohol withdrawal using clomethiazole. Alcohol Alcohol 1995;30:771-774.
19. Hu Y, Mishin V, Johansson I, Von Bahr C, Cross A, Ronis MJJ, Badger TM, et al. Chlormethiazole as an efficient inhibitor of cytochrome P4502E1 expression in rat liver. J Pharmacol Exp Ther 1994;269:1286-1291.
20. Lucas D, Ménez JF, Berthou F. Chlorzoxazone: an in vivo and in vitro substrate probe for liver CYP2E1. In: Johnson EF, Waterman ER, eds. Methods in Enzymology, Cytochrome P450 Part B. Volume 272. Orlando: Academic Press, 1996:115-123.
21. Girre C, Lucas D, Hispard E, Ménez C, Dally S, Ménez JF. Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem Pharmacol 1994;47:1503-1508.
22. Yamzaki H, Guo Z, Guengerich F. Selectivity of cytochrome P4502E1 in chlorzoxazone 6-hydroxylation. Drug Metab Disposit 1995;23:438-440.
23. Bachmann K, Sarver J. Chlorzoxazone as a single sample probe of hepatic CYP2E1 activity in humans. Pharmacology 1996;52:169-177.
24. Lucas D, Ménez C, Girre C, Bodenez P, Hispard E, Ménez JF. Decrease in cytochrome P4502E1 as assessed by the rate of chlorzoxazone hydroxylation in alcoholics during the withdrawal phase. Alcoholism Clin Exp Res 1995;19:362-366.
25. Lucas D, Berthou F, Girre C, Poitrenaud F, Ménez JF. High-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in serum: a tool for indirect evaluation of cytochrome P4502E1 activity in humans. J Chromatogr (Biomed Appl) 1993;622:79-86.
26. Hartley R, Lucock M, Becker M. Improved high-performance liquid chromatographic procedure for the determination of chlormethiazole levels following solid-phase extraction from plasma. J Chromatogr (Biomed Appl) 1987;415:357-364.
27. Perrot N, Nalpas B, Yang CS, Beaune PH. Modulation of cytochrome P450 isozymes in human liver by ethanol. Eur J Clin Invest 1989;19: 549-555.
28. Badger TM, Ronis JJ, Ingelman-Sundberg M, Hakkak R. Inhibition of CYP2E1 activity does not abolish pulsatile urine alcohol concentrations during chronic alcohol infusions. Eur J Biochem 1995;230:914-919.
29. Hoensch HP. Effect of chlormethiazole on the hepatic monooxygenase enzyme system. Acta Psychiatr Scand 1986;73(suppl 329):66-68.
30. Mönig H, Back DJ, Heidemann HT, Ohnhaus EE, Brockmann B, Schulte MH. Effect of chlormethiazole on hepatic monooxygenases activity in vivo. Eur J Clin Pharmacol 1993;44:203-204.
31. Cholerton S, Daly AK, Idl JR. The role of individual human cytochromes P450 in drug metabolism and clinical response. Trends Pharmacol Sci 1992;13:434-439.
32. Wrighton SA, Stevens JC. The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 1992;22:1-21.
33. Grant SK, Green BG, Wang R, Pacholok SG, Kozarich JW. Characterization of inducible nitric oxide synthase by cytochrome P450 substrates and inhibitors. J Biol Chem 1997;272:977-983.
34. Kim SG, Novak RF. The induction of cytochrome P4502E1 by nitrogen-and sulfur-containing heterocycles: expression and molecular regulation. Toxicol Appl Pharmacol 1993;120:257-265.
35. Wang MH, Wade D, Chen L, White S, Yang CS. Probing the active sites of rat and human cytochrome P4502E1 with alcohols and carboxylic acids. Arch Biochem Biophys 1995;317:299-304.
36. Jeong KS, Lee IJ, Roberts BJ, Yoo JK, Lee JW, Song BJ. Transcriptional inhibition of cytochrome P4502E1 (CYP2E1) by a synthetic compound, YH439. Arch Biochem Biophys 1996;9:223-226.
37. Lee SST, Buters JTM, Pineau T, Fernandez-Salguero P, Gonzalez FJ. Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem 1996;271:12063-12067.